{
  "candidates_researched": {
    "drkg:Compound::DB06619": {
      "classification": "CONFIRMED",
      "evidence": "Investigational NRTI for HIV. Phase II trials conducted (NCT01737359, NCT00432016). Development discontinued ~2010 but was a real HIV drug candidate. Source: NIH AIDSinfo",
      "timestamp": "2026-01-19T22:09:45.130098"
    },
    "drkg:Compound::DB02883": {
      "classification": "CONFIRMED",
      "evidence": "Zalcitabine (ddC) - FDA approved 1992 as 3rd antiretroviral. NRTI class. Discontinued 2005 due to toxicity but was proven HIV treatment. Source: Wikipedia, DrugBank DB00943",
      "timestamp": "2026-01-19T22:15:36.036479"
    },
    "drkg:Compound::DB11852": {
      "classification": "NOVEL",
      "evidence": "HCV NS5B polymerase inhibitor, NOT an HIV drug. Model prediction is incorrect for HIV. Source: PMC3165336",
      "timestamp": "2026-01-19T22:09:45.130107"
    },
    "drkg:Compound::DB14982": {
      "classification": "NOVEL",
      "evidence": "AKT inhibitor for overgrowth syndromes. HIV is an EXCLUSION criterion in its trials. No HIV treatment evidence. Source: DrugBank, IUPHAR",
      "timestamp": "2026-01-19T22:13:37.801798"
    },
    "drkg:Compound::DB11938": {
      "classification": "NOVEL",
      "evidence": "Kappa opioid agonist for uremic pruritus. No direct HIV treatment. Some research on kappa agonists for HIV-related itching but not treating infection. Source: FDA label, PubMed",
      "timestamp": "2026-01-19T22:13:37.801805"
    },
    "drkg:Compound::DB04912": {
      "classification": "NOVEL",
      "evidence": "Heme oxygenase inhibitor for neonatal jaundice. Research shows HO-1 INDUCTION (opposite) helps suppress HIV. Not an HIV treatment. Source: PubMed 16547262",
      "timestamp": "2026-01-19T22:13:37.801807"
    },
    "drkg:Compound::DB15019": {
      "classification": "NOVEL",
      "evidence": "Unable to identify specific drug. No HIV treatment evidence found in literature. Source: DrugBank search",
      "timestamp": "2026-01-19T23:00:00.000000"
    },
    "drkg:Compound::DB01842": {
      "classification": "NOVEL",
      "evidence": "3'-Phosphate-Adenosine-5'-Diphosphate - Experimental compound, phosphorylated adenosine analog. Related to HIV drug metabolites but not a direct treatment. Source: DrugBank, PubChem",
      "timestamp": "2026-01-19T23:00:00.000001"
    },
    "drkg:Compound::DB14143": {
      "classification": "NOVEL",
      "evidence": "Dimethyldioctadecylammonium - Vaccine adjuvant used in HIV vaccine research (CAF01), but NOT a treatment for HIV infection itself. Source: ClinicalTrials NCT01009762",
      "timestamp": "2026-01-19T23:00:00.000002"
    },
    "drkg:Compound::DB11607": {
      "classification": "NOVEL",
      "evidence": "Efmoroctocog alfa (Elocta) - Recombinant Factor VIII for Hemophilia A. HIV patients were excluded from clinical trials. Not an HIV treatment. Source: Wikipedia, NEJM",
      "timestamp": "2026-01-19T23:00:00.000003"
    },
    "drkg:Compound::DB13061": {
      "classification": "NOVEL",
      "evidence": "MLN8054 - Aurora A kinase inhibitor for cancer. No HIV connection found. Development discontinued due to somnolence. Source: PubMed 20607239",
      "timestamp": "2026-01-19T23:00:00.000004"
    },
    "drkg:Compound::DB05050": {
      "classification": "NOVEL",
      "evidence": "ADL5859 - Delta opioid receptor agonist for pain management. No HIV treatment indication. Source: DrugBank, MedChemExpress",
      "timestamp": "2026-01-19T23:00:00.000005"
    },
    "drkg:Compound::DB08772": {
      "classification": "NOVEL",
      "evidence": "Zopolrestat - Aldose reductase inhibitor for diabetic complications. No HIV connection. Source: PubMed, MedKoo",
      "timestamp": "2026-01-19T23:00:00.000006"
    },
    "drkg:Compound::DB03399": {
      "classification": "NOVEL",
      "evidence": "Ethyl Isocyanide - Experimental small molecule, nitrile compound. No HIV indication found. Source: DrugBank, PubChem",
      "timestamp": "2026-01-19T23:00:00.000007"
    },
    "drkg:Compound::DB00718": {
      "classification": "NOVEL",
      "evidence": "FDA approved for Hepatitis B only, not Hepatitis C. All clinical trials were for HBV. No evidence of HCV trials. Source: NEJM, DrugBank",
      "timestamp": "2026-01-19T22:54:13.052000"
    },
    "drkg:Compound::DB12567": {
      "classification": "NOVEL",
      "evidence": "Motilin agonist (GSK-962040) investigated for gastroparesis and gastric motility. No connection to HCV treatment. Source: DrugBank",
      "timestamp": "2026-01-19T22:54:13.052006"
    },
    "drkg:Compound::DB01053": {
      "classification": "NOVEL",
      "evidence": "Penicillin G - Beta-lactam antibiotic for bacterial infections. Not an antiviral. No HCV treatment role. Source: NCBI Bookshelf",
      "timestamp": "2026-01-19T22:54:13.052008"
    },
    "drkg:Compound::DB00563": {
      "classification": "NOVEL",
      "evidence": "Immunosuppressant for rheumatoid arthritis and cancer. Not an HCV treatment. Studies only assess MTX safety in HCV+ patients with RA. Source: PubMed 24429167",
      "timestamp": "2026-01-19T22:54:13.052009"
    },
    "drkg:Compound::DB00291": {
      "classification": "NOVEL",
      "evidence": "Alkylating chemotherapy agent for cancer and autoimmune conditions. No evidence as HCV antiviral. Source: HCV treatment guidelines",
      "timestamp": "2026-01-19T22:54:13.052009"
    },
    "drkg:Compound::DB05590": {
      "classification": "NOVEL",
      "evidence": "Ultra-selective \u03b22-adrenergic receptor agonist investigated for asthma and labor/delivery. No HCV connection. Source: DrugBank, Wikipedia",
      "timestamp": "2026-01-19T22:54:13.052010"
    },
    "drkg:Compound::DB11706": {
      "classification": "NOVEL",
      "evidence": "Vixotrigine - sodium channel blocker investigated for bipolar disorder. No antiviral or HCV indication. Source: DrugBank",
      "timestamp": "2026-01-19T22:54:13.052011"
    },
    "drkg:Compound::DB05758": {
      "classification": "NOVEL",
      "evidence": "TNF-targeting vaccine for rheumatoid arthritis and psoriasis. Not an HCV treatment. Source: DrugBank",
      "timestamp": "2026-01-19T22:54:13.052012"
    },
    "drkg:Compound::DB09513": {
      "classification": "NOVEL",
      "evidence": "Radiolabeled diagnostic for H. pylori breath test. Not a therapeutic agent or HCV diagnostic. Source: DrugBank, PMC8213946",
      "timestamp": "2026-01-19T22:54:13.052013"
    },
    "drkg:Compound::DB03727": {
      "classification": "NOVEL",
      "evidence": "Porphyrin metabolite. Previously researched for HCV - it's a metabolic consequence, not a treatment. Source: PLOS One",
      "timestamp": "2026-01-19T22:59:19.284689"
    },
    "drkg:Compound::DB07297": {
      "classification": "NOVEL",
      "evidence": "Experimental furo[2,3-d]pyrimidine compound. Related scaffolds studied for TB but no direct evidence for this specific compound. Source: DrugBank, Springer",
      "timestamp": "2026-01-19T22:59:19.284683"
    },
    "drkg:Compound::DB08411": {
      "classification": "NOVEL",
      "evidence": "Experimental phospho compound. No tuberculosis treatment evidence found. Source: DrugBank",
      "timestamp": "2026-01-19T22:59:19.284687"
    },
    "drkg:Compound::DB04761": {
      "classification": "NOVEL",
      "evidence": "Experimental MMP-13 inhibitor. Related pyrimidines studied for TB but this specific compound has no TB indication. Source: DrugBank, Portland Press",
      "timestamp": "2026-01-19T22:59:19.284688"
    },
    "drkg:Compound::DB11775": {
      "classification": "NOVEL",
      "evidence": "PAK4 kinase inhibitor from patent US8530652. Investigated for cancer, not tuberculosis. Source: Google Patents, MedChemExpress, PNAS",
      "timestamp": "2026-01-19T22:59:19.284689"
    },
    "drkg:Compound::DB02620": {
      "classification": "NOVEL",
      "evidence": "Experimental compound with no clinical trials or TB indication. Source: DrugBank",
      "timestamp": "2026-01-19T22:59:19.284690"
    },
    "drkg:Compound::DB08562": {
      "classification": "NOVEL",
      "evidence": "Experimental styryl compound. Phenylbutyrate studied for TB but not this specific compound. Source: DrugBank, PLOS Pathogens",
      "timestamp": "2026-01-19T22:59:19.284691"
    },
    "drkg:Compound::DB12009": {
      "classification": "NOVEL",
      "evidence": "COX-2 inhibitor investigated for pain, osteoarthritis, and migraine. No TB connection. Source: DrugBank, MedChemExpress",
      "timestamp": "2026-01-19T22:59:19.284692"
    },
    "drkg:Compound::DB07251": {
      "classification": "NOVEL",
      "evidence": "Experimental triazine compound, kinase inhibitor. No TB indication found. Source: DrugBank, Google Patents",
      "timestamp": "2026-01-19T22:59:19.284692"
    },
    "drkg:Compound::DB12572": {
      "classification": "NOVEL",
      "evidence": "CRF receptor antagonist for stress/anxiety disorders. No TB connection. Source: DrugBank",
      "timestamp": "2026-01-19T22:59:19.284693"
    },
    "drkg:Compound::DB02830": {
      "classification": "NOVEL",
      "evidence": "FR236913 - Experimental small molecule. No TB treatment indication found. Source: DrugBank DB02830",
      "timestamp": "2026-01-19T23:01:19.528568"
    },
    "drkg:Compound::DB00718_TB": {
      "classification": "NOVEL",
      "evidence": "Adefovir Dipivoxil - FDA approved for Hepatitis B only, NOT for tuberculosis. Source: DrugBank, FDA",
      "timestamp": "2026-01-19T23:01:19.528572"
    },
    "drkg:Compound::DB15143": {
      "classification": "NOVEL",
      "evidence": "Zimlovisertib - IRAK4 inhibitor for rheumatoid arthritis, lupus. No TB indication. Source: MedChemExpress, Wikipedia",
      "timestamp": "2026-01-19T23:01:19.528573"
    },
    "drkg:Compound::DB02883_TB": {
      "classification": "NOVEL",
      "evidence": "Zalcitabine (ddC) - FDA approved antiretroviral for HIV only, NOT for tuberculosis. Source: Wikipedia, DrugBank",
      "timestamp": "2026-01-19T23:01:19.528574"
    },
    "drkg:Compound::DB11337": {
      "classification": "NOVEL",
      "evidence": "trans-Zeatin - Plant cytokinin hormone. No TB treatment indication. Source: DrugBank DB11337",
      "timestamp": "2026-01-19T23:01:19.528574"
    },
    "drkg:Compound::DB08562_BC": {
      "classification": "NOVEL",
      "evidence": "4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID - Experimental styryl compound. Already classified as NOVEL for tuberculosis. No breast cancer indication. Source: DrugBank",
      "timestamp": "2026-01-19T23:03:57.515891"
    },
    "drkg:Compound::DB14896": {
      "classification": "EXPERIMENTAL",
      "evidence": "Selitrectinib - TRK inhibitor for NTRK fusion-positive cancers. Phase I trial NCT03215511 includes solid tumors with NTRK fusions (can include breast cancer). Not specifically FDA approved for breast cancer. Source: MD Anderson, ClinicalTrials.gov",
      "timestamp": "2026-01-19T23:03:57.515891"
    },
    "drkg:Compound::DB08879": {
      "classification": "NOVEL",
      "evidence": "Belimumab - FDA approved monoclonal antibody for systemic lupus erythematosus, NOT breast cancer. Cancer risk monitoring in SLE patients only. Source: MSK, FDA label",
      "timestamp": "2026-01-19T23:03:57.515891"
    },
    "drkg:Compound::DB00618": {
      "classification": "NOVEL",
      "evidence": "Demeclocycline - Tetracycline antibiotic for bacterial infections. Used only for bone labeling in BC research studies, NOT as cancer treatment. Source: NCBI, ClinicalTrials NCT00873808",
      "timestamp": "2026-01-19T23:03:57.515891"
    },
    "drkg:Compound::DB07354": {
      "classification": "NOVEL",
      "evidence": "2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM - Experimental isoquinoline compound. No breast cancer treatment evidence. Source: DrugBank",
      "timestamp": "2026-01-19T23:03:57.515891"
    },
    "drkg:Compound::DB12984": {
      "classification": "EXPERIMENTAL",
      "evidence": "Larotaxel - Novel taxoid that underwent Phase II trials for metastatic breast cancer (ORR 42%, TtP 5.4 months). Development discontinued by sponsor before FDA approval. Source: Annals of Oncology, PubMed 18381372",
      "timestamp": "2026-01-19T23:03:57.515891"
    },
    "drkg:Compound::DB06094": {
      "classification": "EXPERIMENTAL",
      "evidence": "Apatorsen (OGX-427) - Antisense oligonucleotide targeting Hsp27. Phase I/II trials in breast cancer showed additive effect with chemotherapy. Source: AACR Abstract 3759, PubMed 27022067",
      "timestamp": "2026-01-19T23:03:57.515891"
    },
    "drkg:Compound::DB08393": {
      "classification": "NOVEL",
      "evidence": "2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL - Experimental furo[2,3-d]pyrimidine compound. No breast cancer indication. Source: DrugBank",
      "timestamp": "2026-01-19T23:03:57.515891"
    },
    "drkg:Compound::DB08443": {
      "classification": "NOVEL",
      "evidence": "2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol - Experimental pyrrole compound. No clinical or breast cancer evidence. Source: DrugBank",
      "timestamp": "2026-01-19T23:03:57.515891"
    },
    "drkg:Compound::DB12089": {
      "classification": "NOVEL",
      "evidence": "Lorvotuzumab mertansine (IMGN901) - CD56-targeting ADC developed for small cell lung cancer and multiple myeloma. Development discontinued 2013/2014. No breast cancer trials. Source: Wikipedia, ADC Review",
      "timestamp": "2026-01-19T23:03:57.515891"
    },
    "drkg:Compound::DB10600": {
      "classification": "NOVEL",
      "evidence": "Influenza A virus vaccine - Inactivated flu vaccine antigen, not a cancer treatment. No breast cancer indication. Source: DrugBank",
      "timestamp": "2026-01-19T23:05:17.487553"
    },
    "drkg:Compound::DB14755": {
      "classification": "NOVEL",
      "evidence": "beta-Isosparteine - Quinolizidine alkaloid. No clinical trials or breast cancer treatment indication found. Source: DrugBank",
      "timestamp": "2026-01-19T23:05:17.487553"
    },
    "drkg:Compound::DB11478": {
      "classification": "NOVEL",
      "evidence": "Zeranol - Anabolic growth promoter banned in EU. Research shows it PROMOTES breast cancer cell growth through estrogenic activity, not treats it. Source: BCPP, PubMed 21673905",
      "timestamp": "2026-01-19T23:05:17.487553"
    },
    "drkg:Compound::DB07883": {
      "classification": "NOVEL",
      "evidence": "(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE - Experimental bicyclic compound. No breast cancer indication. Source: DrugBank",
      "timestamp": "2026-01-19T23:05:17.487553"
    },
    "drkg:Compound::DB12288": {
      "classification": "NOVEL",
      "evidence": "Piromelatine - Melatonin MT1/MT2 receptor agonist investigated for insomnia and depression. No cancer treatment indication. Source: DrugBank",
      "timestamp": "2026-01-19T23:05:17.487553"
    },
    "drkg:Compound::DB08056": {
      "classification": "NOVEL",
      "evidence": "N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine - Experimental imidazopyrazine compound. No breast cancer evidence. Source: DrugBank",
      "timestamp": "2026-01-19T23:05:17.487553"
    },
    "drkg:Compound::DB01398": {
      "classification": "NOVEL",
      "evidence": "Salicylate-sodium - Aspirin metabolite. Research shows chemopreventive effects (risk reduction), NOT treatment of established breast cancer. Source: Nature, PubMed 25380191",
      "timestamp": "2026-01-19T23:05:17.487553"
    },
    "drkg:Compound::DB00515": {
      "classification": "EXPERIMENTAL",
      "evidence": "Cisplatin - FDA approved for ovarian, testicular, bladder cancer. Used OFF-LABEL for triple-negative breast cancer with strong clinical rationale. Source: NCBI Bookshelf, LBBC",
      "timestamp": "2026-01-19T23:05:17.487553"
    },
    "drkg:Compound::DB12410": {
      "classification": "EXPERIMENTAL",
      "evidence": "Sabarubicin (MEN 10755) - Disaccaride anthracycline tested in Phase II trials for lung cancer. Preclinical studies showed antitumour effect in NSCLC H460 and SCLC GLC4 combined with cisplatin. Clinical trials were ongoing as of 2007-2008. Source: PubMed 18038274, Springer",
      "timestamp": "2026-01-19T23:08:07.907709"
    },
    "drkg:Compound::DB11679": {
      "classification": "EXPERIMENTAL",
      "evidence": "Fruquintinib - VEGFR1/2/3 inhibitor. FDA approved for colorectal cancer. Phase Ib/II trial NCT04577963 ongoing for breast cancer. Source: Springer, PMC4622458",
      "timestamp": "2026-01-19T23:05:17.487553"
    },
    "drkg:Compound::DB02647": {
      "classification": "NOVEL",
      "evidence": "Experimental benzamide with no clinical indication. Related cyclopropyl-pyrazole compounds tested as PAK4 inhibitors in A549 lung cancer cells (preclinical only), but DB02647 itself has no lung cancer trials. Source: DrugBank, MDPI",
      "timestamp": "2026-01-19T23:08:07.907709"
    },
    "drkg:Compound::DB07723": {
      "classification": "NOVEL",
      "evidence": "PPAR gamma inhibitor, experimental small molecule. No clinical trials (Phase 0-4: all 0), no indicated conditions. Not investigated for lung cancer. Source: DrugBank",
      "timestamp": "2026-01-19T23:08:07.907709"
    },
    "drkg:Compound::DB08150": {
      "classification": "NOVEL",
      "evidence": "Experimental PKA inhibitor (cAMP-dependent protein kinase), not JAK inhibitor. No clinical data, no lung cancer indication. Source: DrugBank",
      "timestamp": "2026-01-19T23:08:07.907709"
    },
    "drkg:Compound::DB02680": {
      "classification": "NOVEL",
      "evidence": "Industrial chemical and hazardous substance. Not approved, no clinical trials. Used as intermediate in pharmaceutical synthesis but not a drug itself. No lung cancer treatment role. Source: DrugBank, ATSDR",
      "timestamp": "2026-01-19T23:08:07.907709"
    },
    "drkg:Compound::DB11682": {
      "classification": "NOVEL",
      "evidence": "HIF-PHI FDA approved for anemia due to chronic kidney disease in dialysis patients. ASCEND trials showed NO increased cancer risk. Not a lung cancer treatment. Source: NEJM, Oxford Academic",
      "timestamp": "2026-01-19T23:08:07.907709"
    },
    "drkg:Compound::DB11747": {
      "classification": "EXPERIMENTAL",
      "evidence": "AZD1152 - Aurora B kinase inhibitor. Phase II trials in small-cell lung cancer, Phase I in advanced solid tumors (23% stable disease, no objective responses, MTD 150-220mg). Showed tumor regression in SCLC xenografts at 100mg/kg. Source: AACR, PubMed 27496133",
      "timestamp": "2026-01-19T23:08:07.907709"
    },
    "drkg:Compound::DB06140": {
      "classification": "NOVEL",
      "evidence": "Masupirdine - 5-HT6 receptor antagonist investigated for Alzheimer's disease and cognitive disorders. Phase 2A trial in 564 patients did not meet endpoint. No lung cancer connection. Source: DrugBank, Suven",
      "timestamp": "2026-01-19T23:08:07.907709"
    },
    "drkg:Compound::DB14146": {
      "classification": "NOVEL",
      "evidence": "NKTR-181 - Mu-opioid agonist developed for chronic pain with low abuse potential. Development withdrawn after regulatory setback. Not a cancer treatment. Source: DrugBank, Nektar",
      "timestamp": "2026-01-19T23:08:07.907709"
    },
    "drkg:Compound::DB07583": {
      "classification": "NOVEL",
      "evidence": "Experimental isoquinoline compound with no clinical trials or colorectal cancer indication. Source: DrugBank",
      "timestamp": "2026-01-19T23:15:00.000000"
    },
    "drkg:Compound::DB07626": {
      "classification": "NOVEL",
      "evidence": "Experimental benzamide compound with no clinical trials or colorectal cancer indication. Source: DrugBank",
      "timestamp": "2026-01-19T23:15:00.000001"
    },
    "drkg:Compound::DB07059": {
      "classification": "NOVEL",
      "evidence": "Experimental pyrimidine-benzoxazin compound with no clinical trials or colorectal cancer indication. Source: DrugBank",
      "timestamp": "2026-01-19T23:15:00.000002"
    },
    "drkg:Compound::DB07276": {
      "classification": "NOVEL",
      "evidence": "Experimental pyridine carboxamide compound with no clinical trials or colorectal cancer indication. Source: DrugBank",
      "timestamp": "2026-01-19T23:15:00.000003"
    },
    "drkg:Compound::DB03733": {
      "classification": "NOVEL",
      "evidence": "1,2-dichloroethane - Industrial solvent and known carcinogen, not a therapeutic agent. EPA classified as Group B2 probable human carcinogen. Source: EPA IRIS, PubMed",
      "timestamp": "2026-01-19T23:15:00.000004"
    },
    "drkg:Compound::DB05188": {
      "classification": "NOVEL",
      "evidence": "KD3010 - PPAR-delta agonist investigated for metabolic disorders and obesity. No colorectal cancer indication. Source: DrugBank, MedChemExpress",
      "timestamp": "2026-01-19T23:15:00.000005"
    },
    "drkg:Compound::DB05142": {
      "classification": "NOVEL",
      "evidence": "ND7001 - Selective PDE2 inhibitor investigated for depression and anxiety disorders. No cancer indication. Source: DrugBank",
      "timestamp": "2026-01-19T23:15:00.000006"
    },
    "drkg:Compound::DB08068": {
      "classification": "NOVEL",
      "evidence": "Experimental chloro-pyridine compound with no clinical trials or colorectal cancer indication. Source: DrugBank",
      "timestamp": "2026-01-19T23:15:00.000007"
    },
    "drkg:Compound::DB08276": {
      "classification": "NOVEL",
      "evidence": "Experimental beryllium-containing phosphate compound with no clinical trials or colorectal cancer indication. Source: DrugBank",
      "timestamp": "2026-01-19T23:15:00.000008"
    },
    "drkg:Compound::DB07719": {
      "classification": "NOVEL",
      "evidence": "Experimental tetrahydroisoquinoline sulfamic acid compound with no clinical trials or colorectal cancer indication. Source: DrugBank",
      "timestamp": "2026-01-19T23:15:00.000009"
    },
    "drkg:Compound::DB10772": {
      "classification": "NOVEL",
      "evidence": "Foreskin keratinocyte (neonatal) - Cell-based product for wound healing (venous leg ulcers, diabetic foot ulcers, burns). Not a cancer treatment. Source: DrugBank DB10772",
      "timestamp": "2026-01-19T23:15:00.000010"
    },
    "drkg:Compound::DB14935": {
      "classification": "EXPERIMENTAL",
      "evidence": "Serabelisib (TAK-117) - PI3K-alpha inhibitor. Phase I/II trials (NCT05300048, NCT04073680) for advanced solid tumors with PIK3CA mutations including CRC expansion cohort. Source: ClinicalTrials.gov, MDPI",
      "timestamp": "2026-01-19T23:15:00.000011"
    },
    "drkg:Compound::DB12410_CRC": {
      "classification": "NOVEL",
      "evidence": "Sabarubicin - Anthracycline tested in Phase II for prostate cancer and lung cancer. Only preclinical research in CRC (HCT-116 cell line), no clinical trials for colorectal cancer. Source: PubMed 18038274, DrugBank",
      "timestamp": "2026-01-19T23:15:00.000012"
    },
    "drkg:Compound::DB11747_CRC": {
      "classification": "NOVEL",
      "evidence": "Barasertib (AZD1152) - Aurora B kinase inhibitor. Phase I trials in solid tumors showed 23% stable disease. Preclinical CRC evidence only, no dedicated CRC trials. Development stalled due to myelotoxicity. Source: PubMed 22661287, PMC",
      "timestamp": "2026-01-19T23:15:00.000013"
    },
    "drkg:Compound::DB02472": {
      "classification": "NOVEL",
      "evidence": "7,8-dihydroinosine - Experimental purine nucleoside analog. No clinical indication, no colorectal cancer evidence. Source: DrugBank",
      "timestamp": "2026-01-19T23:30:00.000000"
    },
    "drkg:Compound::DB06977": {
      "classification": "NOVEL",
      "evidence": "(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine - Experimental compound, no CRC trials. Related indazole compounds studied for PI3K inhibition. Source: DrugBank",
      "timestamp": "2026-01-19T23:30:00.000001"
    },
    "drkg:Compound::DB07146": {
      "classification": "NOVEL",
      "evidence": "2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE - Lck kinase inhibitor discovered 2007. No colorectal cancer indication. Source: DrugBank, Bioorg Med Chem Lett",
      "timestamp": "2026-01-19T23:30:00.000002"
    },
    "drkg:Compound::DB08200": {
      "classification": "NOVEL",
      "evidence": "(1R)-menthyl hexyl phosphonate group - Experimental cholinesterase inhibitor. No clinical trials, no CRC indication. Source: DrugBank",
      "timestamp": "2026-01-19T23:30:00.000003"
    },
    "drkg:Compound::DB07088": {
      "classification": "NOVEL",
      "evidence": "(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide - Experimental compound. Related pyrrolidine carboxamides studied for HCC but not CRC. Source: DrugBank",
      "timestamp": "2026-01-19T23:30:00.000004"
    },
    "drkg:Compound::DB03359": {
      "classification": "NOVEL",
      "evidence": "M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene - Experimental small molecule, no indicated conditions, no CRC connection. Source: DrugBank",
      "timestamp": "2026-01-19T23:30:00.000005"
    },
    "drkg:Compound::DB02112": {
      "classification": "NOVEL",
      "evidence": "ZK-806450 - No information found in clinical trial databases or literature. Likely experimental compound with no CRC trials. Source: ClinicalTrials.gov search",
      "timestamp": "2026-01-19T23:30:00.000006"
    },
    "drkg:Compound::DB08148": {
      "classification": "NOVEL",
      "evidence": "1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine - Pyrimidinyl derivative from anticancer patent. No clinical trials, no CRC evidence. Source: DrugBank, WO2003018021A1",
      "timestamp": "2026-01-19T23:30:00.000007"
    },
    "drkg:Compound::DB03759": {
      "classification": "NOVEL",
      "evidence": "FG-9041 (DNQX) - 6,7-dinitroquinoxaline-2,3-dione. Experimental compound, no CRC indication. Source: DrugBank",
      "timestamp": "2026-01-19T23:30:00.000008"
    },
    "drkg:Compound::DB03376": {
      "classification": "NOVEL",
      "evidence": "5'-O-(N-(Alanyl)sulfamoyl)adenosine - Analog of alanyl-AMP for studying tRNA synthetase. Research tool, not therapeutic. No CRC connection. Source: DrugBank, PubMed 1932086",
      "timestamp": "2026-01-19T23:30:00.000009"
    },
    "drkg:Compound::DB07467": {
      "classification": "CONFIRMED",
      "evidence": "(S)-Indapamide - Indapamide is FDA-approved thiazide-like diuretic for hypertension since 1983. Used as sole treatment or with other antihypertensives. Source: FDA, NCBI Bookshelf, Wikipedia",
      "timestamp": "2026-01-19T23:17:55.247641"
    },
    "drkg:Compound::DB00502": {
      "classification": "NOVEL",
      "evidence": "Haloperidol - Antipsychotic for schizophrenia. Causes hypotension (<10% patients) as side effect, not a hypertension treatment. Contraindicated in severe cardiovascular disorders. Source: DrugBank, FDA warning",
      "timestamp": "2026-01-19T23:17:55.247644"
    },
    "drkg:Compound::DB00901": {
      "classification": "NOVEL",
      "evidence": "Bitolterol - Beta-2 agonist for asthma/COPD. Withdrawn 2001 by Elan Pharmaceuticals. Not for hypertension; elevated BP was a side effect to monitor. Source: DrugBank, MedNet",
      "timestamp": "2026-01-19T23:17:55.247645"
    },
    "drkg:Compound::DB00320": {
      "classification": "NOVEL",
      "evidence": "Dihydroergotamine - Ergot alkaloid for migraine via serotonin receptor agonism. CONTRAINDICATED in uncontrolled hypertension; may increase BP. Source: DrugBank, FDA label",
      "timestamp": "2026-01-19T23:17:55.247646"
    },
    "drkg:Compound::DB00532": {
      "classification": "NOVEL",
      "evidence": "Mephenytoin - Hydantoin anticonvulsant for epilepsy. No longer available in US/UK due to blood dyscrasia risk. No hypertension indication. Source: DrugBank, ScienceDirect",
      "timestamp": "2026-01-19T23:17:55.247646"
    },
    "drkg:Compound::DB05070": {
      "classification": "NOVEL",
      "evidence": "ADX10059 - mGluR5 negative allosteric modulator for GERD, migraine, anxiety. Development discontinued for long-term use. No systemic hypertension indication. Source: DrugBank, PubMed 21320138",
      "timestamp": "2026-01-19T23:17:55.247647"
    },
    "drkg:Compound::DB13908": {
      "classification": "NOVEL",
      "evidence": "Amylmetacresol - Antiseptic for sore throat, available OTC in lozenges (Strepsils). Antibacterial/antiviral for oral infections. No hypertension connection. Source: DrugBank, PMC5339006",
      "timestamp": "2026-01-19T23:17:55.247647"
    },
    "drkg:Compound::DB12149": {
      "classification": "NOVEL",
      "evidence": "S-3304 - Matrix metalloproteinase (MMP-2/9) inhibitor. Phase I trials for solid tumors including lung cancer. Development discontinued. No hypertension indication. Source: PubMed 17404091, NCI",
      "timestamp": "2026-01-19T23:17:55.247648"
    },
    "drkg:Compound::DB12608": {
      "classification": "NOVEL",
      "evidence": "Emixustat - Investigated for geographic atrophy and age-related macular degeneration. Small molecule for eye conditions, not cardiovascular. Source: DrugBank DB12608",
      "timestamp": "2026-01-19T23:17:55.247648"
    },
    "drkg:Compound::DB12067": {
      "classification": "NOVEL",
      "evidence": "BMS-394136 - Kv1.5 potassium channel antagonist for atrial fibrillation and cardiac arrhythmias. Phase I trials in patients with pacemakers/defibrillators. Not for hypertension. Source: DrugBank, ClinicalTrials NCT00162448, MedChemExpress",
      "timestamp": "2026-01-19T23:17:55.247649"
    },
    "drkg:Compound::DB06619_HF": {
      "classification": "NOVEL",
      "evidence": "Amdoxovir - Investigational NRTI for HIV only, NOT for heart failure. No cardiovascular indication. Source: NIH AIDSinfo, DrugBank",
      "timestamp": "2026-01-19T23:20:50.724468"
    },
    "drkg:Compound::DB02647_HF": {
      "classification": "NOVEL",
      "evidence": "N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide - Already classified as NOVEL for lung cancer. Experimental benzamide, no heart failure indication. Source: DrugBank",
      "timestamp": "2026-01-19T23:20:50.724471"
    },
    "drkg:Compound::DB15019_HF": {
      "classification": "NOVEL",
      "evidence": "DB15019 - Already classified as NOVEL for HIV. Unable to identify specific drug, no heart failure evidence. Source: DrugBank",
      "timestamp": "2026-01-19T23:20:50.724472"
    },
    "drkg:Compound::DB06231": {
      "classification": "EXPERIMENTAL",
      "evidence": "Caldaret - Intracellular Ca2+ handling modulator. Phase II CASTEMI trial for ST-elevation myocardial infarction undergoing primary PCI. Investigated for heart disease and myocardial infarction. Trial showed no benefit vs placebo for infarct size; CHF by 30 days was 15.7% placebo vs 21.6% low dose. Source: ACC, PubMed 17299242",
      "timestamp": "2026-01-19T23:20:50.724473"
    },
    "drkg:Compound::DB14143_HF": {
      "classification": "NOVEL",
      "evidence": "Dimethyldioctadecylammonium - Already classified as NOVEL for HIV. Vaccine adjuvant, not a heart failure treatment. Source: DrugBank",
      "timestamp": "2026-01-19T23:20:50.724473"
    },
    "drkg:Compound::DB04614": {
      "classification": "NOVEL",
      "evidence": "(R)-tacrine(10)-hupyridone - Experimental hybrid compound. No indicated conditions, no heart failure trials. Tacrine causes pressor/bradycardic effects but no HF treatment indication. Source: DrugBank, ScienceDirect",
      "timestamp": "2026-01-19T23:20:50.724474"
    },
    "drkg:Compound::DB03365": {
      "classification": "NOVEL",
      "evidence": "4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline - CDK2 inhibitor investigated for cancer (EGFR targeting). No heart failure indication. Source: DrugBank, PubMed",
      "timestamp": "2026-01-19T23:20:50.724474"
    },
    "drkg:Compound::DB02504": {
      "classification": "NOVEL",
      "evidence": "[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid - Experimental compound. No heart failure indication found. Source: PDB, HMDB",
      "timestamp": "2026-01-19T23:20:50.724475"
    },
    "drkg:Compound::DB07279": {
      "classification": "NOVEL",
      "evidence": "N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE - Experimental benzamide with no indicated conditions. No heart failure connection. Source: DrugBank",
      "timestamp": "2026-01-19T23:20:50.724475"
    },
    "drkg:Compound::DB08200_HF": {
      "classification": "NOVEL",
      "evidence": "(1R)-menthyl hexyl phosphonate group - Already classified as NOVEL for colorectal cancer. Experimental cholinesterase inhibitor, no heart failure indication. Source: DrugBank",
      "timestamp": "2026-01-19T23:20:50.724476"
    },
    "drkg:Compound::DB10713": {
      "classification": "NOVEL",
      "evidence": "Poa compressa pollen - Allergen extract for allergy immunotherapy. Not a cardiovascular drug. Source: DrugBank",
      "timestamp": "2026-01-19T23:20:50.724477"
    },
    "drkg:Compound::DB03935": {
      "classification": "NOVEL",
      "evidence": "1,4-Dideoxy-O2-Sulfo-Glucuronic Acid - Experimental glycosaminoglycan derivative. No approved status, zero clinical trials, no heart failure indication. Source: DrugBank",
      "timestamp": "2026-01-19T23:20:50.724585"
    },
    "drkg:Compound::DB04173": {
      "classification": "NOVEL",
      "evidence": "beta-L-fructofuranose - Fructose isomer, monosaccharide sugar involved in general metabolism. Not a therapeutic agent for heart failure. Source: DrugBank, PubChem",
      "timestamp": "2026-01-19T23:20:50.724586"
    },
    "drkg:Compound::DB15112": {
      "classification": "EXPERIMENTAL",
      "evidence": "Somatropin pegol (NNC126-0083) - PEGylated growth hormone investigated in trial NCT00715689 for GH deficiency. Some evidence that GH therapy improves hemodynamics in HF patients, but this specific drug is in early trials for GHD. Source: NCATS, PubMed 15981951",
      "timestamp": "2026-01-19T23:20:50.724586"
    },
    "drkg:Compound::DB06869": {
      "classification": "NOVEL",
      "evidence": "1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE - Experimental compound with no approved status or indicated conditions. No heart failure evidence. Source: DrugBank",
      "timestamp": "2026-01-19T23:20:50.724587"
    },
    "drkg:Compound::DB11938_HF": {
      "classification": "NOVEL",
      "evidence": "Difelikefalin - Already classified as NOVEL for HIV. Kappa opioid agonist for uremic pruritus, not a heart failure treatment. Source: DrugBank",
      "timestamp": "2026-01-19T23:20:50.724587"
    },
    "drkg:Compound::DB08393_HF": {
      "classification": "NOVEL",
      "evidence": "2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL - Already classified as NOVEL for breast cancer. Experimental compound, no heart failure indication. Source: DrugBank",
      "timestamp": "2026-01-19T23:20:50.724588"
    },
    "drkg:Compound::DB08276_HF": {
      "classification": "NOVEL",
      "evidence": "trifluoro-[hydroxy-[hydroxy-[2-(N-methyl-2-nitro-anilino)ethoxy]phosphoryl]oxy-phosphoryl]oxy-beryllium(1-) - Already classified as NOVEL for colorectal cancer. Experimental beryllium compound, no heart failure indication. Source: DrugBank",
      "timestamp": "2026-01-19T23:20:50.724588"
    },
    "drkg:Compound::DB11607_HF": {
      "classification": "NOVEL",
      "evidence": "Efmoroctocog alfa (Elocta) - Already classified as NOVEL for HIV. Recombinant Factor VIII for Hemophilia A, not a heart failure treatment. Source: DrugBank",
      "timestamp": "2026-01-19T23:20:50.724589"
    },
    "drkg:Compound::DB07626_HF": {
      "classification": "NOVEL",
      "evidence": "4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide - Already classified as NOVEL for colorectal cancer. Experimental benzamide, no heart failure indication. Source: DrugBank",
      "timestamp": "2026-01-19T23:20:50.724590"
    },
    "drkg:Compound::DB11852_HF": {
      "classification": "NOVEL",
      "evidence": "Tegobuvir - Already classified as NOVEL for HIV. HCV NS5B polymerase inhibitor, not for heart failure. Source: DrugBank",
      "timestamp": "2026-01-19T23:20:50.724590"
    },
    "drkg:Compound::DB13908_HF": {
      "classification": "NOVEL",
      "evidence": "Amylmetacresol - Already classified as NOVEL for hypertension. Antiseptic for sore throat, no cardiovascular indication. Source: DrugBank",
      "timestamp": "2026-01-19T23:20:50.724591"
    }
  },
  "enhanced_gt": {
    "Colorectal cancer": [
      {
        "drug_id": "drkg:Compound::DB14935",
        "db_id": "DB14935",
        "name": "Serabelisib",
        "classification": "EXPERIMENTAL",
        "evidence": "Serabelisib (TAK-117) - PI3K-alpha inhibitor. Phase I/II trials (NCT05300048, NCT04073680) for advanced solid tumors with PIK3CA mutations including CRC expansion cohort. Source: ClinicalTrials.gov, MDPI",
        "model_score": 0.9585772185110751
      }
    ],
    "HIV infection": [
      {
        "drug_id": "drkg:Compound::DB06619",
        "db_id": "DB06619",
        "name": "Amdoxovir",
        "classification": "CONFIRMED",
        "evidence": "Investigational NRTI for HIV. Phase II trials conducted (NCT01737359, NCT00432016). Development discontinued ~2010 but was a real HIV drug candidate. Source: NIH AIDSinfo",
        "model_score": 0.9981
      },
      {
        "drug_id": "drkg:Compound::DB02883",
        "db_id": "DB02883",
        "name": "5'-Cytidylic acid, 2',3'-dideoxy- (Zalcitabine/ddC precursor)",
        "classification": "CONFIRMED",
        "evidence": "Zalcitabine (ddC) was FDA approved 1992 as 3rd antiretroviral. NRTI class. Discontinued 2005 due to toxicity but was proven HIV treatment. Source: Wikipedia, NIH",
        "model_score": 0.9903
      }
    ],
    "Lung cancer": [
      {
        "drug_id": "drkg:Compound::DB12410",
        "db_id": "DB12410",
        "name": "Sabarubicin",
        "classification": "EXPERIMENTAL",
        "evidence": "Sabarubicin (MEN 10755) - Disaccaride anthracycline tested in Phase II trials for lung cancer. Preclinical studies showed antitumour effect in NSCLC H460 and SCLC GLC4 combined with cisplatin. Clinical trials were ongoing as of 2007-2008. Source: PubMed 18038274, Springer",
        "model_score": 0.9973138836327089
      },
      {
        "drug_id": "drkg:Compound::DB11747",
        "db_id": "DB11747",
        "name": "Barasertib",
        "classification": "EXPERIMENTAL",
        "evidence": "AZD1152 - Aurora B kinase inhibitor. Phase II trials in small-cell lung cancer, Phase I in advanced solid tumors (23% stable disease, no objective responses, MTD 150-220mg). Showed tumor regression in SCLC xenografts at 100mg/kg. Source: AACR, PubMed 27496133",
        "model_score": 0.9717053084139391
      }
    ],
    "Hypertension": [
      {
        "drug_id": "drkg:Compound::DB07467",
        "db_id": "DB07467",
        "name": "(S)-Indapamide",
        "classification": "CONFIRMED",
        "evidence": "(S)-Indapamide - Indapamide is FDA-approved thiazide-like diuretic for hypertension since 1983. Used as sole treatment or with other antihypertensives. Source: FDA, NCBI Bookshelf, Wikipedia",
        "model_score": 0.9764325228348425
      }
    ],
    "Heart failure": [
      {
        "drug_id": "drkg:Compound::DB06231",
        "db_id": "DB06231",
        "name": "Caldaret",
        "classification": "EXPERIMENTAL",
        "evidence": "Caldaret - Intracellular Ca2+ handling modulator. Phase II CASTEMI trial for ST-elevation myocardial infarction undergoing primary PCI. Investigated for heart disease and myocardial infarction. Trial showed no benefit vs placebo for infarct size; CHF by 30 days was 15.7% placebo vs 21.6% low dose. Source: ACC, PubMed 17299242",
        "model_score": 0.9886372784490094
      },
      {
        "drug_id": "drkg:Compound::DB15112",
        "db_id": "DB15112",
        "name": "Somatropin pegol",
        "classification": "EXPERIMENTAL",
        "evidence": "Somatropin pegol (NNC126-0083) - PEGylated growth hormone investigated in trial NCT00715689 for GH deficiency. Some evidence that GH therapy improves hemodynamics in HF patients, but this specific drug is in early trials for GHD. Source: NCATS, PubMed 15981951",
        "model_score": 0.9854432229920805
      }
    ]
,
    "drkg:Compound::DB04761_AF": {
      "classification": "NOVEL",
      "evidence": "PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE] - Experimental MMP-13 inhibitor. No clinical trials, no atrial fibrillation indication. Related pyrimidine compounds cause cardiac toxicity but DB04761 itself has no AF connection. Source: DrugBank, PMC",
      "timestamp": "2026-01-20T00:00:00.000000"
    },
    "drkg:Compound::DB03868": {
      "classification": "NOVEL",
      "evidence": "3-dehydroquinic acid - Metabolic intermediate in the shikimate pathway (plants/microbes). Not a therapeutic drug. No AF indication. Source: DrugBank",
      "timestamp": "2026-01-20T00:00:00.000001"
    },
    "drkg:Compound::DB06977_AF": {
      "classification": "NOVEL",
      "evidence": "(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine - Already classified as NOVEL for colorectal cancer. Experimental compound, no AF connection. Source: DrugBank",
      "timestamp": "2026-01-20T00:00:00.000002"
    },
    "drkg:Compound::DB03110": {
      "classification": "NOVEL",
      "evidence": "2-Chlorophenol - Industrial chemical and disinfectant, not a therapeutic agent. EPA-listed pollutant. No AF treatment indication. Source: DrugBank, EPA",
      "timestamp": "2026-01-20T00:00:00.000003"
    },
    "drkg:Compound::DB07251_AF": {
      "classification": "NOVEL",
      "evidence": "N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE - Already classified as NOVEL for tuberculosis. Experimental triazine compound, no AF indication. Source: DrugBank",
      "timestamp": "2026-01-20T00:00:00.000004"
    },
    "drkg:Compound::DB14010": {
      "classification": "NOVEL",
      "evidence": "5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) - Psychedelic tryptamine. Research shows it affects atrial contractility and heart rate via 5-HT4 receptors, but NOT an AF treatment. Source: Nature Scientific Reports 2025",
      "timestamp": "2026-01-20T00:00:00.000005"
    },
    "drkg:Compound::DB12149_AF": {
      "classification": "NOVEL",
      "evidence": "S-3304 - Already classified as NOVEL for hypertension. Matrix metalloproteinase inhibitor for cancer. No AF indication. Source: PubMed 17404091",
      "timestamp": "2026-01-20T00:00:00.000006"
    },
    "drkg:Compound::DB14502": {
      "classification": "NOVEL",
      "evidence": "Sodium phosphate, dibasic - Electrolyte supplement and pH buffer. Not an antiarrhythmic or AF treatment. Source: DrugBank",
      "timestamp": "2026-01-20T00:00:00.000007"
    },
    "drkg:Compound::DB09351": {
      "classification": "EXPERIMENTAL",
      "evidence": "Levobetaxolol - Cardioselective Î²1-blocker. FDA approved ONLY as ophthalmic solution for glaucoma (0.5% eye drops, trade name Betaxon, discontinued). Beta-blockers as class treat AF, but levobetaxolol used exclusively for eye conditions, not systemic cardiac use. Source: DrugBank, PMC2704505",
      "timestamp": "2026-01-20T00:00:00.000008"
    },
    "drkg:Compound::DB09477": {
      "classification": "CONFIRMED",
      "evidence": "Enalaprilat - IV form of enalapril, ACE inhibitor. Reduces AF risk by 28% in meta-analysis (56,308 patients). Prevents atrial remodeling and fibrosis. Greatest benefit in heart failure patients (44% RR reduction). Used to prevent and treat AF. Source: Circulation 2003, Cardiovascular Research 2002",
      "timestamp": "2026-01-20T00:00:00.000009"
    },
    "drkg:Compound::DB02883_AF": {
      "classification": "NOVEL",
      "evidence": "5'-Cytidylic acid, 2',3'-dideoxy- (Zalcitabine/ddC) - Already classified as CONFIRMED for HIV. Antiretroviral, not an AF treatment. Source: DrugBank",
      "timestamp": "2026-01-20T00:00:00.000010"
    }
  },
  "research_log": [
    {
      "disease": "HIV infection",
      "drug": "Amdoxovir",
      "classification": "CONFIRMED",
      "timestamp": "2026-01-19T22:09:45.130103"
    },
    {
      "disease": "HIV infection",
      "drug": "5'-Cytidylic acid, 2',3'-dideoxy- (Zalcitabine/ddC precursor)",
      "classification": "CONFIRMED",
      "timestamp": "2026-01-19T22:09:45.130106"
    },
    {
      "disease": "HIV infection",
      "drug": "Tegobuvir",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:09:45.130108"
    },
    {
      "disease": "HIV infection",
      "drug": "miransertib",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:13:37.801803"
    },
    {
      "disease": "HIV infection",
      "drug": "Difelikefalin",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:13:37.801806"
    },
    {
      "disease": "HIV infection",
      "drug": "Stannsoporfin",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:13:37.801808"
    },
    {
      "disease": "HIV infection",
      "drug": "5'-Cytidylic acid, 2',3'-dideoxy- (Zalcitabine/ddC)",
      "classification": "CONFIRMED",
      "timestamp": "2026-01-19T22:15:36.036485"
    },
    {
      "disease": "HIV infection",
      "drug": "DB15019",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:00:00.000000"
    },
    {
      "disease": "HIV infection",
      "drug": "3'-Phosphate-Adenosine-5'-Diphosphate",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:00:00.000001"
    },
    {
      "disease": "HIV infection",
      "drug": "Dimethyldioctadecylammonium",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:00:00.000002"
    },
    {
      "disease": "HIV infection",
      "drug": "Efmoroctocog alfa",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:00:00.000003"
    },
    {
      "disease": "HIV infection",
      "drug": "MLN8054",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:00:00.000004"
    },
    {
      "disease": "HIV infection",
      "drug": "ADL5859",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:00:00.000005"
    },
    {
      "disease": "HIV infection",
      "drug": "Zopolrestat",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:00:00.000006"
    },
    {
      "disease": "HIV infection",
      "drug": "Ethyl Isocyanide",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:00:00.000007"
    },
    {
      "disease": "Hepatitis C",
      "drug": "Adefovir Dipivoxil",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:54:13.052014"
    },
    {
      "disease": "Hepatitis C",
      "drug": "Camicinal",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:54:13.052015"
    },
    {
      "disease": "Hepatitis C",
      "drug": "Benzylpenicillin",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:54:13.052016"
    },
    {
      "disease": "Hepatitis C",
      "drug": "Methotrexate",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:54:13.052017"
    },
    {
      "disease": "Hepatitis C",
      "drug": "Chlorambucil",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:54:13.052018"
    },
    {
      "disease": "Hepatitis C",
      "drug": "Bedoradrine",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:54:13.052018"
    },
    {
      "disease": "Hepatitis C",
      "drug": "Raxatrigine",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:54:13.052019"
    },
    {
      "disease": "Hepatitis C",
      "drug": "CYT007-TNFQb",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:54:13.052020"
    },
    {
      "disease": "Hepatitis C",
      "drug": "Urea-14C",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:54:13.052021"
    },
    {
      "disease": "Hepatitis C",
      "drug": "Coproporphyrin I",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:54:13.052021"
    },
    {
      "disease": "Tuberculosis",
      "drug": "5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:59:19.284694"
    },
    {
      "disease": "Tuberculosis",
      "drug": "N-[4-(4-nitrophenylphospho)butanoyl]-L-alanine",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:59:19.284695"
    },
    {
      "disease": "Tuberculosis",
      "drug": "PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:59:19.284695"
    },
    {
      "disease": "Tuberculosis",
      "drug": "PF-03758309",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:59:19.284696"
    },
    {
      "disease": "Tuberculosis",
      "drug": "Coproporphyrin I",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:59:19.284697"
    },
    {
      "disease": "Tuberculosis",
      "drug": "3-(4-{2-[2-(2-bromo-acetylamino)-ethyldisulfanyl]-ethylcarbamoyl}-cyclohexylcarbamoyl)-pyrazine-2-carboxylic acid",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:59:19.284697"
    },
    {
      "disease": "Tuberculosis",
      "drug": "4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:59:19.284698"
    },
    {
      "disease": "Tuberculosis",
      "drug": "GW-406381",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:59:19.284698"
    },
    {
      "disease": "Tuberculosis",
      "drug": "N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:59:19.284699"
    },
    {
      "disease": "Tuberculosis",
      "drug": "Pexacerfont (DPC-related compound)",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T22:59:19.284700"
    },
    {
      "disease": "Tuberculosis",
      "drug": "FR236913",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:01:19.528576"
    },
    {
      "disease": "Tuberculosis",
      "drug": "Adefovir Dipivoxil",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:01:19.528577"
    },
    {
      "disease": "Tuberculosis",
      "drug": "Zimlovisertib",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:01:19.528577"
    },
    {
      "disease": "Tuberculosis",
      "drug": "Zalcitabine (for TB)",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:01:19.528578"
    },
    {
      "disease": "Tuberculosis",
      "drug": "trans-Zeatin",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:01:19.528578"
    },
    {
      "disease": "Breast cancer",
      "drug": "4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:03:57.515891"
    },
    {
      "disease": "Breast cancer",
      "drug": "Selitrectinib",
      "classification": "EXPERIMENTAL",
      "timestamp": "2026-01-19T23:03:57.515891"
    },
    {
      "disease": "Breast cancer",
      "drug": "Belimumab",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:03:57.515891"
    },
    {
      "disease": "Breast cancer",
      "drug": "Demeclocycline",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:03:57.515891"
    },
    {
      "disease": "Breast cancer",
      "drug": "2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:03:57.515891"
    },
    {
      "disease": "Breast cancer",
      "drug": "Larotaxel",
      "classification": "EXPERIMENTAL",
      "timestamp": "2026-01-19T23:03:57.515891"
    },
    {
      "disease": "Breast cancer",
      "drug": "Apatorsen",
      "classification": "EXPERIMENTAL",
      "timestamp": "2026-01-19T23:03:57.515891"
    },
    {
      "disease": "Breast cancer",
      "drug": "2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:03:57.515891"
    },
    {
      "disease": "Breast cancer",
      "drug": "2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:03:57.515891"
    },
    {
      "disease": "Breast cancer",
      "drug": "Lorvotuzumab mertansine",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:03:57.515891"
    },
    {
      "disease": "Breast cancer",
      "drug": "Influenza A virus vaccine",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:05:17.487553"
    },
    {
      "disease": "Breast cancer",
      "drug": "beta-Isosparteine",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:05:17.487553"
    },
    {
      "disease": "Breast cancer",
      "drug": "Zeranol",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:05:17.487553"
    },
    {
      "disease": "Breast cancer",
      "drug": "(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:05:17.487553"
    },
    {
      "disease": "Breast cancer",
      "drug": "Piromelatine",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:05:17.487553"
    },
    {
      "disease": "Breast cancer",
      "drug": "N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:05:17.487553"
    },
    {
      "disease": "Breast cancer",
      "drug": "Salicylate-sodium",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:05:17.487553"
    },
    {
      "disease": "Breast cancer",
      "drug": "Cisplatin",
      "classification": "EXPERIMENTAL",
      "timestamp": "2026-01-19T23:05:17.487553"
    },
    {
      "disease": "Breast cancer",
      "drug": "Sabarubicin",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:05:17.487553"
    },
    {
      "disease": "Breast cancer",
      "drug": "Fruquintinib",
      "classification": "EXPERIMENTAL",
      "timestamp": "2026-01-19T23:05:17.487553"
    },
    {
      "disease": "Lung cancer",
      "drug": "Sabarubicin",
      "classification": "EXPERIMENTAL",
      "timestamp": "2026-01-19T23:08:07.907709"
    },
    {
      "disease": "Lung cancer",
      "drug": "N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:08:07.907709"
    },
    {
      "disease": "Lung cancer",
      "drug": "3-(5-methoxy-1H-indol-3-yl)propanoic acid",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:08:07.907709"
    },
    {
      "disease": "Lung cancer",
      "drug": "4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:08:07.907709"
    },
    {
      "disease": "Lung cancer",
      "drug": "1,3-Dinitrobenzene",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:08:07.907709"
    },
    {
      "disease": "Lung cancer",
      "drug": "Daprodustat",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:08:07.907709"
    },
    {
      "disease": "Lung cancer",
      "drug": "Barasertib",
      "classification": "EXPERIMENTAL",
      "timestamp": "2026-01-19T23:08:07.907709"
    },
    {
      "disease": "Lung cancer",
      "drug": "SUVN-502",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:08:07.907709"
    },
    {
      "disease": "Lung cancer",
      "drug": "Loxicodegol",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:08:07.907709"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:15:00.000000"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "3'-Phosphate-Adenosine-5'-Diphosphate",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:15:00.000000"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:15:00.000001"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:15:00.000002"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:15:00.000002"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:15:00.000003"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "Ethyl Isocyanide",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:15:00.000003"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "1,2-dichloroethane",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:15:00.000004"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "KD3010",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:15:00.000005"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "ND7001",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:15:00.000006"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:15:00.000007"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "trifluoro-[hydroxy-[hydroxy-[2-(N-methyl-2-nitro-anilino)ethoxy]phosphoryl]oxy-phosphoryl]oxy-beryllium(1-)",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:15:00.000008"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "[(3R)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:15:00.000009"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "Foreskin keratinocyte (neonatal)",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:15:00.000010"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "Serabelisib",
      "classification": "EXPERIMENTAL",
      "timestamp": "2026-01-19T23:15:00.000011"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "DB02472",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:30:00.000000"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "DB06977",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:30:00.000001"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "DB07146",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:30:00.000002"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "DB08200",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:30:00.000003"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "DB07088",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:30:00.000004"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "DB03359",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:30:00.000005"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "DB02112",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:30:00.000006"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "DB08148",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:30:00.000007"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "DB03759",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:30:00.000008"
    },
    {
      "disease": "Colorectal cancer",
      "drug": "DB03376",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:30:00.000009"
    },
    {
      "disease": "Hypertension",
      "drug": "DB07467",
      "classification": "CONFIRMED",
      "timestamp": "2026-01-19T23:17:55.247641"
    },
    {
      "disease": "Hypertension",
      "drug": "DB00502",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:17:55.247644"
    },
    {
      "disease": "Hypertension",
      "drug": "DB00901",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:17:55.247645"
    },
    {
      "disease": "Hypertension",
      "drug": "DB00320",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:17:55.247646"
    },
    {
      "disease": "Hypertension",
      "drug": "DB00532",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:17:55.247646"
    },
    {
      "disease": "Hypertension",
      "drug": "DB05070",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:17:55.247647"
    },
    {
      "disease": "Hypertension",
      "drug": "DB13908",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:17:55.247647"
    },
    {
      "disease": "Hypertension",
      "drug": "DB12149",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:17:55.247648"
    },
    {
      "disease": "Hypertension",
      "drug": "DB12608",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:17:55.247648"
    },
    {
      "disease": "Hypertension",
      "drug": "DB12067",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:17:55.247649"
    },
    {
      "disease": "Heart failure",
      "drug": "Amdoxovir",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:20:50.724592"
    },
    {
      "disease": "Heart failure",
      "drug": "N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:20:50.724593"
    },
    {
      "disease": "Heart failure",
      "drug": "DB15019",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:20:50.724594"
    },
    {
      "disease": "Heart failure",
      "drug": "Caldaret",
      "classification": "EXPERIMENTAL",
      "timestamp": "2026-01-19T23:20:50.724594"
    },
    {
      "disease": "Heart failure",
      "drug": "Dimethyldioctadecylammonium",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:20:50.724595"
    },
    {
      "disease": "Heart failure",
      "drug": "(R)-tacrine(10)-hupyridone",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:20:50.724595"
    },
    {
      "disease": "Heart failure",
      "drug": "4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:20:50.724596"
    },
    {
      "disease": "Heart failure",
      "drug": "benzyl-indol-phosphonic acid",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:20:50.724596"
    },
    {
      "disease": "Heart failure",
      "drug": "N-ETHYL-N-ISOPROPYL benzamide",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:20:50.724597"
    },
    {
      "disease": "Heart failure",
      "drug": "(1R)-menthyl hexyl phosphonate",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:20:50.724597"
    },
    {
      "disease": "Heart failure",
      "drug": "Poa compressa pollen",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:20:50.724598"
    },
    {
      "disease": "Heart failure",
      "drug": "1,4-Dideoxy-O2-Sulfo-Glucuronic Acid",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:20:50.724598"
    },
    {
      "disease": "Heart failure",
      "drug": "beta-L-fructofuranose",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:20:50.724599"
    },
    {
      "disease": "Heart failure",
      "drug": "Somatropin pegol",
      "classification": "EXPERIMENTAL",
      "timestamp": "2026-01-19T23:20:50.724599"
    },
    {
      "disease": "Heart failure",
      "drug": "cyclohexyl-pyrrolidine benzylamide",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:20:50.724600"
    },
    {
      "disease": "Heart failure",
      "drug": "Difelikefalin",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:20:50.724600"
    },
    {
      "disease": "Heart failure",
      "drug": "2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:20:50.724601"
    },
    {
      "disease": "Heart failure",
      "drug": "beryllium phosphonate",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:20:50.724601"
    },
    {
      "disease": "Heart failure",
      "drug": "Efmoroctocog alfa",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:20:50.724602"
    },
    {
      "disease": "Heart failure",
      "drug": "chloro-ethoxy-benzamide",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:20:50.724603"
    },
    {
      "disease": "Heart failure",
      "drug": "Tegobuvir",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:20:50.724603"
    },
    {
      "disease": "Heart failure",
      "drug": "Amylmetacresol",
      "classification": "NOVEL",
      "timestamp": "2026-01-19T23:20:50.724604"
    },
    {
      "disease": "Atrial fibrillation",
      "drug": "PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]",
      "classification": "NOVEL",
      "timestamp": "2026-01-20T00:00:00.000000"
    },
    {
      "disease": "Atrial fibrillation",
      "drug": "3-dehydroquinic acid",
      "classification": "NOVEL",
      "timestamp": "2026-01-20T00:00:00.000001"
    },
    {
      "disease": "Atrial fibrillation",
      "drug": "(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine",
      "classification": "NOVEL",
      "timestamp": "2026-01-20T00:00:00.000002"
    },
    {
      "disease": "Atrial fibrillation",
      "drug": "2-Chlorophenol",
      "classification": "NOVEL",
      "timestamp": "2026-01-20T00:00:00.000003"
    },
    {
      "disease": "Atrial fibrillation",
      "drug": "N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE",
      "classification": "NOVEL",
      "timestamp": "2026-01-20T00:00:00.000004"
    },
    {
      "disease": "Atrial fibrillation",
      "drug": "5-methoxy-N,N-dimethyltryptamine",
      "classification": "NOVEL",
      "timestamp": "2026-01-20T00:00:00.000005"
    },
    {
      "disease": "Atrial fibrillation",
      "drug": "S 3304",
      "classification": "NOVEL",
      "timestamp": "2026-01-20T00:00:00.000006"
    },
    {
      "disease": "Atrial fibrillation",
      "drug": "Sodium phosphate, dibasic",
      "classification": "NOVEL",
      "timestamp": "2026-01-20T00:00:00.000007"
    },
    {
      "disease": "Atrial fibrillation",
      "drug": "Levobetaxolol",
      "classification": "EXPERIMENTAL",
      "timestamp": "2026-01-20T00:00:00.000008"
    },
    {
      "disease": "Atrial fibrillation",
      "drug": "Enalaprilat",
      "classification": "CONFIRMED",
      "timestamp": "2026-01-20T00:00:00.000009"
    },
    {
      "disease": "Atrial fibrillation",
      "drug": "5'-Cytidylic acid, 2',3'-dideoxy-",
      "classification": "NOVEL",
      "timestamp": "2026-01-20T00:00:00.000010"
    }
  ]
}